Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220019327 220007164 1.65 99 Curative (C) 2016-02-28 2016-06-05 AML18 PILOT TRIAL N Y 220027518 PILOT TRIAL
220019328 220007166 1.75 103.8 Curative (C) 2015-03-03 2015-03-17 ALEMTUZUMAB + FLUDARABINE + MELPHALAN Y N 220027534 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019329 220013953 1.69 86.5 Curative (C) 2013-04-18 2013-06-03 AML18 PILOT TRIAL N N 220027551 PILOT TRIAL
220019330 220007174 1.85 90 Curative (C) 2016-02-03 2016-02-03 Alemtuz+Fludara+Melphalan RIC MUD N N 220027553 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019331 220013956 null 62 Curative (C) 2014-05-07 2014-08-03 AML18 PILOT TRIAL Y N 220027583 PILOT TRIAL
220019332 220007182 1.81 64.8 Curative (C) 2013-04-28 2013-05-04 Alemtuz+Fludara+Melphalan RIC MUD N N 220027594 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019333 220017598 1.61 56 Curative (C) 2013-12-15 2013-12-23 Alemtuz+Fludara+Melphalan RIC MUD N N 220027595 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019334 220007185 1.91 89.65 Curative (C) 2014-05-28 2014-06-15 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220027600 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019335 220007191 1.82 69.3 Curative (C) 2016-06-04 2016-06-08 AML 18 TRIAL 1 N 220027617 AML18 TRIAL
220019336 220007197 1.71 89.3 Curative (C) null 2015-04-19 AML18 PILOT TRIAL Y null 220027658 PILOT TRIAL
220019337 220007201 1.8 91.1 Curative (C) 2014-09-15 2014-11-23 AML18 PILOT TRIAL null N 220027659 PILOT TRIAL
220019338 220013967 1.7 78.4 Curative (C) 2015-09-26 2015-10-02 AML 18 TRIAL 01 N 220027663 AML18 TRIAL
220019339 220007204 1.5 65.7 Curative (C) 2015-08-06 2015-09-24 AML 18 TRIAL 1 N 220027665 AML18 TRIAL
220019340 220007213 1.67 87.1 Curative (C) 2014-10-08 2014-12-16 AML 18 TRIAL N N 220027691 AML18 TRIAL
220019341 220007217 1.49 0 Palliative (P) 2016-02-11 2016-02-11 Dasatinib N N 220027703 DASATINIB
220019342 220007221 1.63 0 Curative (C) 2017-11-20 2017-11-20 Dasatinib N N 220027709 DASATINIB
220019343 220007222 1.78 133 Curative (C) 2016-04-08 2016-04-09 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N null 220027726 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019344 220007230 1.6 null Disease modification (D) 2016-11-29 2016-12-06 Rituximab N N 220027754 RITUXIMAB
220019345 220007233 1.57 89.3 Curative (C) 2013-07-10 2013-11-08 AML18 PILOT TRIAL Y N 220027773 PILOT TRIAL
220019346 220007235 1.5 82.2 Curative (C) 2015-05-20 2015-05-20 Dasatinib 02 N 220027774 DASATINIB
220019347 220007240 1.63 null Palliative (P) 2010-07-19 2013-05-17 Dasatinib N N 220027806 DASATINIB
220019348 220007247 1.63 63.1 Curative (C) 2012-02-23 2013-08-10 Dasatinib N N 220027816 DASATINIB
220019349 220013987 1.62 46.3 Curative (C) 2014-09-17 2014-10-30 AML18 PILOT TRIAL 1 N 220027821 PILOT TRIAL
220019350 220007250 1.67 null Disease modification (D) 2018-05-20 2018-05-21 Dasatinib 2 N 220027826 DASATINIB
220019351 220017616 1.77 null Adjuvant (A) 2015-02-09 2015-02-09 Dasatinib 02 null 220027828 DASATINIB
220019352 220007252 1.67 77.9 Disease modification (D) 2014-12-23 2014-12-23 Alemtuz+Fludara+Melphalan RIC MUD N N 220027831 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019353 220007254 1.62 95.2 Curative (C) 2015-06-05 2016-01-26 Rituximab N N 220027834 RITUXIMAB
220019354 220019654 1.77 65.8 Curative (C) 2017-11-20 2017-12-01 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220027861 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019355 220007260 1.55 null Curative (C) 2014-12-31 2015-01-01 Alemtuz+Fludara+Melphalan RIC MUD 02 null 220027874 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019356 220007260 1.67 65.7 Palliative (P) 2014-05-03 2014-05-03 Dasatinib 2 N 220027874 DASATINIB
220019357 220013996 1.86 75 Curative (C) 2018-05-30 2018-05-31 Rituximab Y N 220027894 RITUXIMAB
220019358 220007265 1.69 78 Curative (C) 2015-05-18 2015-06-02 Rituximab N null 220027906 RITUXIMAB
220019359 220007269 1.79 57.8 Curative (C) 2017-06-24 2017-06-29 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220027908 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019360 220014003 1.61 98.9 Curative (C) 2016-02-24 2016-04-07 AML 18 TRIAL Y N 220027940 AML18 TRIAL
220019361 220017626 1.93 61.2 Curative (C) 2017-09-13 2017-12-01 AML18 PILOT TRIAL Y null 220027944 PILOT TRIAL
220019362 220007280 1.63 0 Disease modification (D) 2017-02-16 2017-02-16 Rituximab N null 220027960 RITUXIMAB
220019363 220007282 1.53 78.6 Adjuvant (A) 2015-03-25 2015-05-20 Dasatinib N N 220027982 DASATINIB
220019364 220007296 1.69 null Curative (C) 2015-06-09 2015-11-28 Dasatinib N N 220028090 DASATINIB
220019365 220020848 1.58 70 Curative (C) 2017-01-31 2017-01-31 Alemtuz+Fludara+Melphalan RIC MUD N N 220028109 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019366 220007298 0 59.5 Disease modification (D) 2016-08-05 2016-08-07 Rituximab 02 N 220028118 RITUXIMAB
220019367 220007299 1.77 77.7 Disease modification (D) 2013-04-17 2013-08-14 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220028136 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019368 220007302 1.62 71.8 Palliative (P) 2013-08-26 2013-08-27 AML 18 TRIAL N N 220028138 AML18 TRIAL
220019369 220007304 0 79.6 Curative (C) 2017-02-12 2017-03-17 Rituximab N N 220028139 RITUXIMAB
220019370 220007305 1.8 null Curative (C) 2016-02-08 2016-02-09 Dasatinib N N 220028145 DASATINIB
220019371 220007307 null 95.2 Disease modification (D) 2014-05-27 2014-09-19 AML18 PILOT TRIAL N N 220028151 PILOT TRIAL
220019372 220020852 1.79 54 Curative (C) 2016-12-21 2016-12-21 Rituximab N N 220028152 RITUXIMAB
220019373 220007311 1.7 49.9 null 2013-07-21 2013-09-13 AML 18 TRIAL Y N 220028170 AML18 TRIAL
220019374 220007313 1.9 76.75 Curative (C) 2015-10-29 2016-01-01 Alemtuz+Fludara+Melphalan RIC MUD N null 220028174 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019376 220017645 1.7 83 Curative (C) 2015-04-01 2015-04-01 AML18 PILOT TRIAL N N 220028201 PILOT TRIAL
220019377 220022207 0 72 Curative (C) 2015-12-02 2016-03-08 AML18 PILOT TRIAL N N 220028203 PILOT TRIAL